1. Academic Validation
  2. S-Acyl-2-thioethyl aryl phosphotriester derivatives as mononucleotide prodrugs

S-Acyl-2-thioethyl aryl phosphotriester derivatives as mononucleotide prodrugs

  • J Med Chem. 2000 Nov 16;43(23):4570-4. doi: 10.1021/jm000996o.
N Schlienger 1 S Peyrottes T Kassem J L Imbach G Gosselin A M Aubertin C Périgaud
Affiliations

Affiliation

  • 1 UMR 5625 CNRS-UM II, Université Montpellier II, cc 008, place E. Bataillon, 34095 Montpellier Cedex 05, France.
Abstract

The synthesis and biological activities of phosphotriester derivatives of 3'-azido-2',3'-dideoxythymidine (AZT) bearing a phenyl group or L-tyrosinyl residues are reported. The target compounds were obtained via either P(V) or P(III) chemistry from the appropriate aryl precursors. All the derivatives were evaluated for their in vitro anti-HIV activity, and they appeared to be potent inhibitors of HIV-1 replication in various Cell Culture experiments, with EC(50) values between the micro- and nanomolar range. Furthermore, compounds incorporating an amino- and/or acid-substituted tyrosinyl residue demonstrated significant anti-HIV effects in thymidine kinase-deficient (TK(-)) cells showing their ability to act as mononucleotide prodrugs. The proposed decomposition process of these mixed mononucleoside aryl phosphotriesters may involve esterase activation followed by phosphodiesterase hydrolysis.

Figures